QLS-1304

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS-1304, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors [Phase 1]